Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

MEA 2021 masthead 1

Medical Ethics Advisor – February 1, 2013

February 1, 2013

View Archives Issues

  • New disclosure requirements could have some unintended consequences

    If a patient finds out her doctor prescribed a medication manufactured by a drug company he happens to have a lucrative consulting contract with, will she view this as an indication that he's prominent in his field or that he has "sold out" to the industry?
  • ACA could facilitate shared decision-making

    There is still "a good deal of confusion" about what informed consent and shared decision-making really are, according to Howard Brody, MD, PhD, John P. McGovern Centennial Chair in Family Medicine and director of the Institute for the Medical Humanities at the University of Texas Medical Branch at Galveston.
  • Ethics of new emphasis on comparative effectiveness

    The Affordable Care Act (ACA) will put more emphasis on both comparative effectiveness and cost-effectiveness, and this raises important ethical considerations, according to Gary E. Jones, PhD, JD, professor in the Philosophy Department at University of San Diego (CA).
  • Change in DSM-5: "Step in right direction"

    The use of bipolar disorder diagnoses for children whose primary symptoms were manifested by irritability, rather than the traditional cyclical mood symptoms of adult bipolar disorder, has been a major concern in child psychiatry in recent years, says Paul S. Appelbaum, MD, Dollard Professor of Psychiatry, Medicine, and Law and director of the Division of Law, Ethics, and Psychiatry at Columbia University College of Physicians & Surgeons in New York City.
  • Ethics of postmortem implant explantation are overlooked

    Explantation of battery-operated implants such as pacemakers involves pressing ethical issues but receives little attention, according to Katrina A. Bramstedt, PhD, a clinical ethicist and associate professor at Bond University School of Medicine in Australia, and former faculty in the Department of Bioethics at Cleveland Clinic Foundation, Cleveland, OH.
  • New requirements for organ donor screening

    Some hospitals are now being required to inform living donors of the risks they face, fully evaluate their medical and psychological suitability, and track their health for years after donation.
  • Providers: Ethically obligated to give easier access to records?

    Both autonomy and the law favor allowing patients access to their medical records, and there are clearly associated benefits, says Gregory R. Moore, MD, MPH, senior director at Stamps Health Services at Georgia Institute of Technology in Atlanta.